Webinar:  Identifying and Removing False Positives in Immunoassays


Now available on-demand!
Immunoassay development and performance


WEBINAR TOPIC


Immunoassays are commonly used to quantify biomarkers in complex sample matrices. In order to do this accurately, immunoassays need to be developed to control for various factors present in these matrices. When not controlled for, assays can display false positives, false negatives, or under-report values due to interference. R&D Systems has more than 30 years of experience developing and optimizing immunoassays to control for these factors. In this webinar, our scientists demonstrate how we identify and control for matrix effects in Quantikine® ELISAs and Luminex® Assays.


SPEAKERS


Mandy Kubik

Mandy Kubik

Assay Development Manager
Bio-Techne


Mandy Kubik is a Manager of Assay Development for Bio-Techne. She has more than 20 years of experience in assay and antibody development. Mandy has extensive experience with antibody screening for multiple Bio-Techne assay platforms. She personally developed many monoclonal antibodies and Quantikine ELISAs in Bio-Techne’s portfolio. Currently, Mandy leads the Quantikine ELISA Development team at Bio-Techne.

Richard Fuerstenberg

Richard Fuerstenberg

Senior Scientist - Immunoassay Development
Bio-Techne



Richard Fuerstenberg is a Senior Scientist for Bio-Techne with a specialty in immunoassay development and applications. Richard has more than 30 years of experience in assay development and was a long time R&D Manager for Bio-Techne. He has in-depth technical knowledge on all of the Bio-Techne assay platforms and has now assumed a customer facing role in order to utilize his expertise and advise on applications and development. Most recently Richard's focus has been on developing novel applications for multiplex assays.